Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma

Neuroblastoma is the most common extracranial solid tumor found in children and despite intense multi-modal therapeutic approaches, low overall survival rates of high-risk patients persist. Tumors with heterozygous loss of chromosome 11q and MYCN amplification are two genetically distinct subsets of...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Kaylee M., Eleveld, Thomas F., Schild, Linda, van den Handel, Kim, van den Boogaard, Marlinde, Amo-Addae, Vicky, Eising, Selma, Ober, Kimberley, Koopmans, Bianca, Looijenga, Leendert, Tytgat, Godelieve A.M., Ylstra, Bauke, Molenaar, Jan J., Dolman, M. Emmy M., van Hooff, Sander R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552537/
https://www.ncbi.nlm.nih.gov/pubmed/36237330
http://dx.doi.org/10.3389/fonc.2022.929123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552537/
https://www.ncbi.nlm.nih.gov/pubmed/36237330
http://dx.doi.org/10.3389/fonc.2022.929123

Ejemplares similares